
When will Compass Pathways submit a NDA for COMP360 psilocybin?
K 17.8K contracts
1
3

- Reported volume
- K 17.8K contracts
- Events
- 1
- Markets
- 3
Current odds
Snapshot from
As of Nov 22, 2026, 3:00 PM UTC, the highest-priced outcome on Kalshi is before April 2027 at 98.5%.
Kalshi
- before April 202798.5%
- before 202798%
- before December96%
Yes prices. They are not order quotes; check each platform's rules, fees and live prices before trading.
AI Analysis
Trader mode: Market mechanics, assumptions and risks
K 17.8K contracts
Reported volume · provider units
3
Saved contracts
0
Same-question pairs
Source snapshot: Nov 22, 2026, 3:00 PM UTC
This analysis was written from an earlier market snapshot, so its prices may be older than the odds above.
Snapshot observed Nov 11, 2026, 3:00 PM UTC. This analysis describes that snapshot and is not a live news update.
What the contract measures
This contract asks whether COMPASS Pathways plc will submit a New Drug Application (NDA) for COMP360 psilocybin to the FDA within a stated window. The provider's rule text says that if the company "submits a NDA for COMP360 psilocybin to the FDA before X 1, 2027, then the market resolves to Yes" [1]. The "X" appears as supplied, and the individual market titles give the specific cutoffs. The rules also say the market "will close and expire early if the event occurs" [1].
The saved event contains three markets with different cutoff dates:
- Before December: the listed end date is December 8, 2026, 15:00 UTC.
- Before 2027: the listed end date is January 8, 2027, 15:00 UTC.
- Before April 2027: the listed end date is April 8, 2027, 14:00 UTC [1].
Because each market has a different window, a Yes outcome in an earlier window also implies Yes in the later windows, but the markets are priced separately.
Reading the snapshot
The snapshot was observed at 15:00 UTC on November 11, 2026, and retrieved at 16:38 UTC the same day [1]. It records prices, not executable quotes or verified probabilities. The reported Yes prices were 0.96 for the December window, 0.965 for the 2027 window, and 0.975 for the April 2027 window [1].
The three markets are all included in the saved sample, and the provider reports no partial sampling. Each market's listed prices are a snapshot from that observation time only, and they should not be read as the current state of the contract. The markets are sorted by Yes price within this one event, so the order does not rank different events against each other.
The No prices (0.04, 0.035, and 0.025) are simply the complements in the snapshot [1]. The evidence does not explain why any price was at its level.
What remains uncertain
The evidence contains only one provider excerpt and one observation. It does not describe the company's regulatory progress, public statements, or any announced submission plan, so these prices cannot be linked to specific events. The listed provider end time is "not supplied" [1]. The saved sample also does not establish that the provider lists every possible outcome for this question.
References
- Kalshi: When will Compass Pathways submit a NDA for COMP360 psilocybin?. Provider data observed Nov 11, 2026, 3:00 PM UTC.
Snapshot observed Nov 11, 2026, 3:00 PM UTC. This analysis describes that snapshot and is not a live news update.
What the contract measures
The Kalshi event asks when COMPASS Pathways plc will submit a new drug application (NDA) for COMP360 psilocybin to the FDA. The source rule states: "If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before X 1, 2027, then the market resolves to Yes." [1] The rule text includes an early close condition: "This market will close and expire early if the event occurs." [1] The provider lists the event as active, with no listed end time supplied. [1]
The saved event contains three markets with different deadlines. Each has its own Yes and No prices and its own listed end date: December 2026 (listed end Dec 8, 2026, 3:00 PM UTC), before 2027 (Jan 8, 2027, 3:00 PM UTC), and before April 2027 (Apr 8, 2027, 2:00 PM UTC). [1] The listed end dates are contract metadata, not announced events. The rule text's "X 1, 2027" wording does not clearly match these three titles, so readers should check each market's own wording before comparing them.
Reading the snapshot
The prices were observed at Nov 11, 2026, 3:00 PM UTC and retrieved at Nov 11, 2026, 4:38 PM UTC. [1] They describe that window only and should not be read as live quotes. The Yes prices were 0.96 for the December deadline, 0.965 for the before-2027 deadline, and 0.975 for the before-April-2027 deadline. The matching No prices were 0.04, 0.035, and 0.025. [1]
Because the deadlines are nested, the later windows have higher Yes prices in this snapshot. These are quoted prices, not verified probabilities or executable trades. The snapshot does not show trading volume in a form that indicates liquidity or the number of participants, and it does not explain why any price is where it is.
All three saved markets are included, and the sample is not marked partial. [1] The source also notes that this does not establish that the provider lists every possible outcome. [1] Because these are different deadlines on one event, there is no single combined figure to report.
What remains uncertain
The evidence does not show any news about the NDA timeline, any statement from the company or regulator, or any reason for the observed prices. It also does not establish whether the saved snapshot still matches live market conditions. Any difference in price between these contracts reflects only the saved quotes and their wording, not a trading opportunity.
References
- Kalshi: When will Compass Pathways submit a NDA for COMP360 psilocybin?. Provider data observed Nov 11, 2026, 3:00 PM UTC.
AI-generated analysis based on market data. Not financial advice.
Saved Nov 11, 2026 UTCThis article was written from an earlier market snapshot and may be out of date. Use the dated market data and provider rules above for current information.
Overview
This PredictPedia entry covers a Kalshi contract asking when COMPASS Pathways plc will submit a new drug application (NDA) for COMP360 psilocybin to the FDA [1]. The contract's stated rule is that if COMPASS Pathways plc submits the NDA to the FDA before the date named in each market, the market resolves to Yes [1]. The source lists an early close condition: the market closes and expires early if the event occurs [1]. The saved provider event contains three markets with different cutoffs. One asks about a submission before December, one asks about a submission before 2027, and one asks about a submission before April 2027 [1]. The saved end dates for these markets are December 8, 2026, January 8, 2027, and April 8, 2027. The provider's listed end time for the event was not supplied in the source [1]. Because these are separate markets with different cutoffs, their results can differ depending on whether a submission happens before each deadline. The event was listed as active when the source was retrieved [1]. The prices attached to these markets are snapshots taken at the observation time. They are not executable quotes and should not be read as verified probabilities of a submission.
Why It Matters
The contract measures a single defined event: whether COMPASS Pathways plc submits an NDA for COMP360 psilocybin to the FDA before a specified cutoff [1]. Under the stated rule, a submission before a cutoff resolves that market to Yes, and the early close condition ends trading once the event occurs [1]. Traders following the contract therefore watch for a formal NDA submission, not for related regulatory discussions or announcements, because the rule is written around the submission itself [1]. The source does not describe how a submission would be publicly confirmed, so readers should check the contract rules directly for resolution details.
Snapshot context
The latest published provider snapshot for this topic was observed on 2026-11-11 at 15:00 UTC. It contains listings from Kalshi. Market descriptions and listed closing times define the contracts; they do not establish that the real-world outcome has occurred. This article does not include a separately verified news update. [1]
Frequently Asked Questions
What event makes the contract resolve Yes?
The market resolves to Yes if COMPASS Pathways plc submits a new drug application for COMP360 psilocybin to the FDA before the cutoff named in the specific market [1].
What happens after the event occurs?
The contract includes an early close condition, so the market closes and expires early if the event occurs [1].
Are the three markets the same contract?
They share one event, but each market uses a different cutoff: December, 2027 in general, and April 2027 [1]. Their prices should be compared only within the context of their own deadlines.
AI-written background. References identify the evidence used; Wikipedia links under Learn More are additional reading. Prices and provider rules are dated snapshots. This is not financial advice.
Related prediction markets
Prices are catalog snapshots and may have changed. Check each market's rules and observation time.

When will the FDA approve Compass Pathways' COMP360 Psilocybin?
K 28.1K contracts
When will Beam Therapeutics submit a BLA for Risto-cel?
K 11.2K contracts
Will the U.S. confirm that aliens exist?
PM $79.85M · K 35.90M contractsWill the US confirm that aliens exist before 2027?
Kalshi: Will the U.S. confirm that aliens exist before 2027?
Same question, fine print differs
Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.
Saved prices; check contract rules.

Best LLM at the end of the decade?
PM $8.74M · K 21.57M contractsWill Google have the best AI model at the end of November 2026?
Kalshi: Best AI this week (Gemini)
Related contracts
Will Google have the best AI model at the end of November 2026?
Kalshi: Best LLM at the end of the decade? (Google)
Related contracts
Will Google have the best AI model at the end of November 2026?
Kalshi: Which AI companies will have a Pareto efficient model at the end of 2026? (Google)
Related contracts
Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.
Saved prices; check contract rules.

Next pandemic
PM $21.80M · K 1.16M contractsHantavirus pandemic in 2026?
Kalshi: Pandemic by Dec 31, 2027?
Related contracts
New pandemic in 2026?
Kalshi: Pandemic by Dec 31, 2027?
Related contracts
New Coronavirus Pandemic in 2026?
Kalshi: Pandemic in 2026?
Related contracts
Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.
Saved prices; check contract rules.

Measles cases in U.S. in 2026?
PM $8.44M · K 765.8K contractsWill there be at least 6000 measles cases in the U.S. in 2026?
Kalshi: Will there be more than 6000 measles cases in 2026?
Related contracts
Will there be at least 7000 measles cases in the U.S. in 2026?
Kalshi: Will there be more than 7000 measles cases in 2026?
Related contracts
Will there be at least 10000 measles cases in the U.S. in 2026?
Kalshi: Will there be more than 10000 measles cases in 2026?
Related contracts
Related or unreviewed contracts may settle differently. Their gap is not an equivalent-contract comparison.
Saved prices; check contract rules.
Market Insights
Price gaps of 2 pp+
0
Same-question pairs
0
No outcomes on this page have been reviewed as the same question on both platforms yet.
Price differences do not establish arbitrage. Check each pair's review, current order prices, fees and settlement rules.
